{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T16:41:22Z","timestamp":1758818482528},"reference-count":29,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Urol\u00f3gicas Espa\u00f1olas"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.acuro.2014.04.007","type":"journal-article","created":{"date-parts":[[2014,6,11]],"date-time":"2014-06-11T17:05:59Z","timestamp":1402506359000},"page":"647-654","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["C\u00e1lculo del riesgo biol\u00f3gico de multirrecidiva y progresi\u00f3n del carcinoma urotelial no m\u00fasculo-invasivo mediante nuevos modelos matem\u00e1ticos"],"prefix":"10.1016","volume":"38","author":[{"given":"S.","family":"Luj\u00e1n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Santamar\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.L.","family":"Pontones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.L.","family":"Ruiz-Cerd\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Trassierra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.D.","family":"Vera-Donoso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Solsona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Jim\u00e9nez-Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.acuro.2014.04.007_bib0005","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2,596 patients from seven EORTC trials","volume":"49","author":"Sylvester","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuro.2014.04.007_bib0010","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.eururo.2013.06.003","article-title":"EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: Update 2013","volume":"64","author":"Babjuk","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuro.2014.04.007_bib0015","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.juro.2013.08.049","article-title":"Bladder cancer in Spain 2011: Population based study","volume":"191","author":"Mi\u00f1ana","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.acuro.2014.04.007_bib0020","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00345-009-0395-z","article-title":"Economic aspects of bladder cancer: What are the benefits and costs?","volume":"27","author":"Sievert","year":"2009","journal-title":"World J Urol"},{"key":"10.1016\/j.acuro.2014.04.007_bib0025","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1002\/sim.3161","article-title":"Investigating trial and treatment heterogeneity in an individual patient data meta-analysis of survival data by means of the penalized maximum likelihood approach","volume":"27","author":"Rondeau","year":"2008","journal-title":"Stat Med"},{"key":"10.1016\/j.acuro.2014.04.007_bib0030","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.eururo.2011.05.033","article-title":"The EORTC tables overestimate the risk of recurrence and progression in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Gu\u00e9rin: External validation of the EORTC risk tables","volume":"60","author":"Fernandez-Gomez","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuro.2014.04.007_bib0035","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S1569-9056(02)80474-2","article-title":"Intravesical chemotherapy for superficial bladder tumours: 5 year follow-up of a randomised trial comparing early single dose vs delayed long-term chemotherapy vs no treatment","volume":"1","author":"Burgu\u00e9s","year":"2002","journal-title":"Eur Urol Suppl"},{"key":"10.1016\/j.acuro.2014.04.007_bib0040","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1464-410X.2010.09515.x","article-title":"The WHO classification of 1973 is more suitable than the WHO classification of 2004 for predicting survival in pT1 urothelial bladder cancer","volume":"107","author":"Otto","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.acuro.2014.04.007_bib0045","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1001\/jama.1982.03320430047030","article-title":"Evaluating the yield of medical tests","volume":"247","author":"Harrell","year":"1982","journal-title":"JAMA"},{"key":"10.1016\/j.acuro.2014.04.007_bib0050","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1100\/tsw.2006.404","article-title":"Natural history, recurrence, and progression in superficial bladder cancer","volume":"6","author":"Sylvester","year":"2006","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.acuro.2014.04.007_bib0055","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0022-5347(17)38731-1","article-title":"Prognostic factors for recurrence and followup policies in the treatment of superficial bladder cancer: Report from the British Medical Research Council Subgroup on superficial bladder cancer (urological cancer working party)","volume":"142","author":"Parmar","year":"1989","journal-title":"J Urol"},{"key":"10.1016\/j.acuro.2014.04.007_bib0060","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1464-410X.1990.tb14861.x","article-title":"Clinical study of prognostic factors of superficial bladder cancer treated with intravesical bacillus Calmette-Gu\u00e9rin","volume":"66","author":"Shinka","year":"1990","journal-title":"BJU Int"},{"key":"10.1016\/j.acuro.2014.04.007_bib0065","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1464-410X.1994.tb07604.x","article-title":"Prognostic factors in pTa-pT1 superficial bladder tumours treated with intravesical instillations","volume":"73","author":"Mulders","year":"1994","journal-title":"BJU Int"},{"key":"10.1016\/j.acuro.2014.04.007_bib0070","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1016\/0959-8049(95)00287-S","article-title":"Factors affecting recurrence and progression in superficial bladder tumours","volume":"31","author":"Kurth","year":"1995","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.acuro.2014.04.007_bib0075","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1046\/j.1442-2042.1999.06441.x","article-title":"Analysis of prognostic factors related to primary superficial bladder cancer tumor recurrence in prophylactic intravesicalepirubicin therapy","volume":"6","author":"Kondo","year":"1999","journal-title":"Int J Urol"},{"key":"10.1016\/j.acuro.2014.04.007_bib0080","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0022-5347(05)67975-X","article-title":"Multivariate analysis of the prognostic factors of primary superficial bladder cancer","volume":"163","author":"Millan-Rodriguez","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.acuro.2014.04.007_bib0085","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.eururo.2007.10.006","article-title":"Prognostic factors in patients with non\u2013muscle-invasive bladder cancer treated with bacillus Calmette-Gu\u00e9rin: Multivariate analysis of data from four randomized CUETO trials","volume":"53","author":"Fernandez-Gomez","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuro.2014.04.007_bib0090","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/0959-8049(94)E0133-O","article-title":"Dysplasia in normal-looking urothelium increases the risk of tumour progression in primary superficial bladder cancer","volume":"30","author":"Kiemeney","year":"1994","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.acuro.2014.04.007_bib0095","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00345-010-0635-2","article-title":"External validation and applicability of the EORTC risk tables for non-muscle-invasive bladder cancer","volume":"29","author":"Hern\u00e1ndez","year":"2011","journal-title":"World J Urol"},{"key":"10.1016\/j.acuro.2014.04.007_bib0100","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S1569-9056(09)61003-4","article-title":"Modelling the recurrence process in non-invasive bladder cancer: Develop a postoperative nomogram","volume":"8","author":"Luj\u00e1n","year":"2009","journal-title":"Eur Urol Suppl"},{"key":"10.1016\/j.acuro.2014.04.007_bib0105","doi-asserted-by":"crossref","first-page":"428","DOI":"10.3346\/jkms.2008.23.3.428","article-title":"Nomograms for prediction of disease recurrence in patients with primary Ta, T1 transitional cell carcinoma of the bladder","volume":"23","author":"Hong","year":"2008","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.acuro.2014.04.007_bib0110","first-page":"548","article-title":"Improvements on cross-validation: The 632+ bootstrap method","volume":"92","author":"Efron","year":"2012","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.acuro.2014.04.007_bib0115","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.juro.2010.08.083","article-title":"Usefulness of the Spanish urological club for oncological treatment scoring model to predict nonmuscle invasive bladder cancer recurrence in patients treated with intravesical bacillus Calmette-Gu\u00e9rin plus interferon-\u03b1","volume":"185","author":"Rosevear","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.acuro.2014.04.007_bib0120","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/jnci\/90.10.766","article-title":"A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer","volume":"90","author":"Kattan","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.acuro.2014.04.007_bib0125","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1038\/bjc.2013.372","article-title":"Accuracy of the EORTC risk tables and of the CUETO scoring model to predict outcomes in non-muscle-invasive urothelial carcinoma of the bladder","volume":"109","author":"Xylinas","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.acuro.2014.04.007_bib0130","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1046\/j.1464-410X.2003.04360.x","article-title":"Superficial bladder tumours: Analysis of prognostic factors and construction of a predictive index","volume":"92","author":"Ali-El-Dein","year":"2003","journal-title":"BJU Int"},{"key":"10.1016\/j.acuro.2014.04.007_bib0135","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1136\/jcp.2010.079764","article-title":"Constructing prognostic model incorporating the 2004 WHO\/ISUP classification for patients with non-muscle-invasive urothelialtumours of the urinary bladder","volume":"63","author":"Pan","year":"2010","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.acuro.2014.04.007_bib0140","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1097\/01.ju.0000154696.48217.75","article-title":"Nomograms including nuclear matrix protein 22 for prediction of disease recurrence and progression in patients with Ta, T1 or CIS transitional cell carcinoma of the bladder","volume":"173","author":"Shariat","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.acuro.2014.04.007_bib0145","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.eururo.2009.06.028","article-title":"Recurrence and progression of disease in non-muscle-invasive bladder cancer: From epidemiology to treatment strategy","volume":"56","author":"Van Rhijn","year":"2009","journal-title":"Eur Urol"}],"container-title":["Actas Urol\u00f3gicas Espa\u00f1olas"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210480614001697?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210480614001697?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,11]],"date-time":"2019-08-11T08:56:36Z","timestamp":1565513796000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0210480614001697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0210480614001697"],"URL":"https:\/\/doi.org\/10.1016\/j.acuro.2014.04.007","relation":{},"ISSN":["0210-4806"],"issn-type":[{"value":"0210-4806","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"C\u00e1lculo del riesgo biol\u00f3gico de multirrecidiva y progresi\u00f3n del carcinoma urotelial no m\u00fasculo-invasivo mediante nuevos modelos matem\u00e1ticos","name":"articletitle","label":"Article Title"},{"value":"Actas Urol\u00f3gicas Espa\u00f1olas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acuro.2014.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 AEU. Published by Elsevier Espa\u00f1a, S.L. All rights reserved.","name":"copyright","label":"Copyright"}]}}